Science
ASCO: Now and Then
- Advocacy
- Anatomic Pathology
- Business
- Clinical Laboratories
- Clinical Pathology
- Conferences
- Current Affairs
- Digital Pathology Conferences
- Digital Pathology News
- Education
- Health Technology Collaboration
- Histology
- Humor
- Informatics
- Laboratory Informatics
- Medical Research
- Microscopy
- Molecular Pathology
- Pathology News
- Personal
- Reports
- Science
- Whole slide
In medical school I drove a cab at night to make ends meet. I rented the medallion from a guy for $50 and kept the difference I made. The Army paid me $692 a month stipend on the Health Professions Scholarship and the studio apartment in...
From CNN: The five-year cancer survival rate in the US has reached 70% for the first time, according to an American Cancer Society report released yesterday. The figure, based on diagnoses from 2015 to 2021, is up from 49% in...
The Ohio State University's James Cancer Hospital makes advancements on lobular breast cancer screening While researchers work to improve lobular breast cancer screening, innovative treatments are improving outcomes for patients with the...
ORNL: Artificial Intelligence researchers have taken a major step forward in using AI in the fight against cancer. In partnership with the National Cancer Institute, or NCI, researchers from the Department of Energy’s Oak Ridge National...
Digital pathology is just pathology, but does it matter anymore?
- Advocacy
- Anatomic Pathology
- Artificial Intelligence
- Clinical Laboratories
- Current Affairs
- Data Management
- Digital Pathology News
- Education
- FDA Approval
- General Healthcare News
- Health Technology Collaboration
- Laboratory Management & Operations
- Microscopy
- Molecular Pathology
- Pathology News
- Personal
- Science
- TeleHealth
- Web/Tech
- Whole slide
Since the 1990s, many innovators to Fortune 500 and Fortune 50 companies have worked to make digital pathology a reality. While not mainstream and perhaps less than 10% of US based pathology groups have any serious implementations of digital...
FRANKFURT, May 10 (Reuters) - Scientific journal Nature on Wednesday said a personalised treatment based on messenger RNA by BioNTech (22UAy.DE) potentially bodes well for the future of fighting an extremely aggressive form of cancer after the...
































